Antibiotic Resistance of Uropathogens Isolated from Al-Shifa Hospital in Gaza Strip in 2002

References

• Sader HS, Gales AC, Pfaller MA. et al. Pathogen fre-quency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial sur-veillance program. Braz J Infect Dis, 2001;.5, 4: 200–214.
   PubMedGoogle Scholar
• Kahlmeter G. An international survey of the antimicro-bial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO•SENS Project. J Antimicrob Chemother 2003; 51: 69–76.
   PubMed Web of Science ®Google Scholar
• Matute AJ, Hak E, Schurink CA, et al. Resistance of uropathogens in symptomatic urinary tract infections in Leon, Nicaragua. Int J Antimicrob Agents. 2004; 23 (5): 506–9.
   PubMed Web of Science ®Google Scholar
• Haller M, Brandis M, Berner R. Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol. 2004; 19 (9): 982-6. Epub 2004 Jun 18.
   Google Scholar
• Turnidge J, Bell J, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents. 2002; 20 (1): 10–7.
   PubMed Web of Science ®Google Scholar
• Mathai D, Jones RN, Pfaller MA. Epidemiology and fre-quency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis. 2001; 40 (3): 129–36.
   PubMed Web of Science ®Google Scholar
• Winstanley TG, Limb DI, Eggington R, Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother 1997; 40: 591–4.
   PubMed Web of Science ®Google Scholar
• Trienekens T, Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother. 1994; 33: 1064–6.
   PubMed Web of Science ®Google Scholar
• Gordon KA, Jones RN. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: com-parison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis. 2003; 45 (4): 295-301.
   Google Scholar
• Jones RN, Kugler KC, Pfaller MA, Winokur PL. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis. 1999; 35 (1): 55–63.
   PubMed Web of Science ®Google Scholar
• Pape L, Gunzer F, Ziesing S, Pape A, Offner G, Ehrich JH. Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infec-tion. Klin Padiatr. 2004; 216 (2): 83–6.
   PubMed Web of Science ®Google Scholar
• Semra K, Suheyla S, Cenk S, Horu G, Mehmet G, Beril O. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections dur-ing 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005; 58: 159–161.
   Google Scholar
• Lavanya SV, Jogalakshmi D. Asymptomatic bacteriuria in antenatal women Indian J Med Microbiol 2002; 20: 105–106.
   PubMedGoogle Scholar
• WHO. Guidelines on Standard Operating Procedures for Microbiology. http://w3.whosea.org/microbio/
   Google Scholar
• Baron EJ, Peterson LR, Finegold SM. 9'h ed. Diagnostic Microbiology. Mosby Year Book. USA 1994;
   Google Scholar
• Saracli MA, Baysallar M, Gan H. Nosocomial uropathogens and their antibiotic susceptibilities in a Turkish Military Hospital: a prospective and microbiological study. Turk J Med Sci, 1999; 29: 165–168.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. ll'h Informational Supplement. Document M100-S11. NCCLS 2001: Wayne, Pa.
   Google Scholar
• Obi CL, Tarupiwa A, Simango C. Scope of urinary pathogens isolated in the Public Health Bacteriology Laboratory, Harare: antibiotic susceptibility patterns of isolates and incidence of haemolytic bacteria. Cent Afr J Med. 1996; 42 (8): 244-9. Comment in: Cent Afr J Med. 1997; 43 (1): 26-7.
   Google Scholar
• Astal Z, Elmanama A, Elkichaoui A, Sharif F. Antibiotic resistance of bacteria associated with community acquired uri-nary tract infections in the southern area of Gaza Strip. Egypt J Med Lab Sci 2001; 10 (2): 23–31.
   Google Scholar
• Gales AC, Jones RN, Gordon KA, et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimi-crobial surveillance program (1998). J Antimicrob Chemother. 2000; 45 (3): 295–303.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among urinary tract infec-tion (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie VanLeeuwenhoek. 2000; 77 (2): 147–52.
   PubMed Web of Science ®Google Scholar
• Raka L, Mulliqi-Osmani G, Berisha L, et al. Etiology and susceptibility of urinary tract isolates in Kosova. Int J Antimicrob Agents. 2004;23 Suppl 1: S2–5.
   PubMedGoogle Scholar
• Khan SW, Ahmed A. Uropathogens and their suscepti-bility pattern: a retrospective analysis. J Pak Med Assoc. 2001; 51 (2): 98–100.
   PubMedGoogle Scholar
• Shao HF, Wang WP, Zhang XW, Li ZD. Distribution and resistance trends of pathogens from urinary tract infec-tions and impact on management. Zhonghua Nan Ke Xue. 2003; (9): 690-2, 696.
   Google Scholar
• Iqbal J, Rahman M, Kabir MS, Rahman M. Increasing ciprofloxacin resistance among prevalent urinary tract isolates in Bangladesh. Jpn J Med Sci Biol. 1997; 50 (6): 241–250.
   PubMedGoogle Scholar
• Ena J, Lopez-Perezagua M, Martinez-Peinado C, Cia-Barrio M, Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquin-lones. Diagn Microbiol Infect Dis. 1988; 30: 103–107.
   Google Scholar
• Kachroo B. Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli. Chemotherapy 2001; 47 (2): 97–103.
   PubMed Web of Science ®Google Scholar
• Wang - H,Dzink-Fox JL, Chen M, Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 2001; 45 (5): 1515–1521.
   PubMed Web of Science ®Google Scholar
• Raz R, Okev N, Kennes Y, Gilboa A, Lavi I., Bisharat N. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in Northern Israel. Isr Med Assoc J 2000; 2.
   PubMedGoogle Scholar